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Abstract
Hydrogen sulfide (H2S) has been shown to induce transient receptor potential vanilloid 1 (TRPV1)-mediated neurogenic
inflammation in polymicrobial sepsis. However, endogenous neural factors that modulate this event and the molecular
mechanism by which this occurs remain unclear. Therefore, this study tested the hypothesis that whether substance P (SP) is
one important neural element that implicates in H2S-induced neurogenic inflammation in sepsis in a TRPV1-dependent
manner, and if so, whether H2S regulates this response through activation of the extracellular signal-regulated kinase-
nuclear factor-kB (ERK-NF-kB) pathway. Male Swiss mice were subjected to cecal ligation and puncture (CLP)-induced sepsis
and treated with TRPV1 antagonist capsazepine 30 minutes before CLP. DL-propargylglycine (PAG), an inhibitor of H2S
formation, was administrated 1 hour before or 1 hour after sepsis, whereas sodium hydrosulfide (NaHS), an H2S donor, was
given at the same time as CLP. Capsazepine significantly attenuated H2S-induced SP production, inflammatory cytokines,
chemokines, and adhesion molecules levels, and protected against lung and liver dysfunction in sepsis. In the absence of
H2S, capsazepine caused no significant changes to the PAG-mediated attenuation of lung and plasma SP levels, sepsis-
associated systemic inflammatory response and multiple organ dysfunction. In addition, capsazepine greatly inhibited
phosphorylation of ERK1/2 and inhibitory kBa, concurrent with suppression of NF-kB activation even in the presence of
NaHS. Furthermore, capsazepine had no effect on PAG-mediated abrogation of these levels in sepsis. Taken together, the
present findings show that H2S regulates TRPV1-mediated neurogenic inflammation in polymicrobial sepsis through
enhancement of SP production and activation of the ERK-NF-kB pathway.
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Introduction
The neuropeptide substance P (SP) is an 11 amino acid peptide
encoded by the preprotachykinin-A (PPT-A) gene. It is distributed
throughout the nervous system of human and animal species [1,2].
Belonging to the tachykinin family of neurotransmitters, SP is well
recognized for its numerous potent neuroimmunomodulatory
actions. Its biological activities are primarily mediated through
neurokinin-1 receptor. SP has been established to exert a vast
range of proinflammatory effects in vitro and in vivo, influencing
many immune and inflammatory disorders of the respiratory,
gastrointestinal, and musculoskeletal systems [2]. SP activates
inflammatory cells to produce various inflammatory molecules
such as cytokines, chemokines, reactive oxygen species, and
arachidonic acid derivatives that potentiate tissue inflammation,
and vasoactive substances like histamine and serotonin that
promote vascular leakiness and edema at the injured tissue site
[1,2]. Additionally, SP provokes lymphocyte proliferation, immu-
noglobulin production, leukocyte chemotaxis, and activation of
proinflammatory transcription factors; all of which exacerbate
tissue injury and amplify the overall inflammatory response [2].
Therefore, it is obvious that an extensive neuro-immune
intersystem crosstalk exist between SP and the inflammatory
response to injury.
Neurogenic inflammation encompasses a series of inflammatory
responses triggered by the activation of primary sensory neurons and
the subsequent release of inflammatory neuropeptides [3]. Of major
importance in the development of neurogenic inflammation is the
transient receptor potential vanilloid type 1 (TRPV1) receptor, a non-
selective cation channel that is best characterized for its location on
these neurons [4]. Besides integrating painful stimuli, TRPV1-
expressing sensory nerve terminals play a dominant role in initiating
neural inflammatory processes [3]. In particular, activation of
TRPV1 by noxious stimuli, including hydrogen sulfide (H2S), leads
to depolarization with consequent releaseof neuropeptides such asSP
that participates in neurogenic inflammation [5].
In recentyears, H2S hasbeen recognized as the third endogenous
signaling gasotransmitter, alongside carbon monoxide and nitric
oxide.Cystathionine-b-synthase(CBS)inthe centralnervoussystem
andcystathionine-c-lyase (CSE) inthe cardiovascular system arethe
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PLoS ONE | www.plosone.org 2 September 2011 | Volume 6 | Issue 9 | e24535Figure 1. Effect of NaHS and capsazepine on protein and mRNA levels of SP in septic mice. Mice were randomly given NaHS (10 mg/kg,
i.p.) or vehicle (DMSO) at the same time of CLP; and capsazepine (Capz) (15 mg/kg, s.c.) or vehicle (DMSO) 30 minutes before CLP. Sham mice were
used as controls. Eight hours after CLP or sham operation, (A) lung and (B) plasma SP levels, and (C) lung PPT-A mRNA levels were measured. Results
shown are the mean values 6 SEM (n=8–12 mice per group). *P,0.01 versus sham; **P,0.01 versus CLP+vehicle; {P,0.05 versus CLP+vehicle;
{P,0.01 versus CLP+NaHS+vehicle.
doi:10.1371/journal.pone.0024535.g001
Figure 2. Effect of NaHS and capsazepine on protein levels of cytokines and chemokines in the lungs and liver of septic mice. Mice
were randomly given NaHS (10 mg/kg, i.p.) or vehicle (DMSO) at the same time of CLP; and capsazepine (Capz) (15 mg/kg, s.c.) or vehicle (DMSO)
30 minutes before CLP. Sham mice were used as controls. Eight hours after CLP or sham operation, protein levels of (A) TNF-a, (B) IL-1b, (C) IL-6, (D)
MIP-1a and (E) MIP-2 were measured. Results shown are the mean values 6 SEM (n=8–12 mice per group). *P,0.01 versus sham; **P,0.01 versus
CLP+vehicle; {P,0.05 versus CLP+vehicle; {P,0.01 versus CLP+NaHS+vehicle.
doi:10.1371/journal.pone.0024535.g002
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H2S [6]. Besides acting as a vasodilator and neuromodulator [7,8],
H2S functions as a cardiovascular modulator and was associated
withvascular consequences of endotoxic and septic shock [9].It also
contributes to local and systemic inflammation seen in experimental
models of hind paw edema, acute pancreatitis, endotoxemia, and
cecal ligation and puncture (CLP)-induced sepsis [6]. Importantly,
our earlier work has demonstrated that H2S promotes TRPV1-
mediated neurogenic inflammation in polymicrobial sepsis [10].
However, endogenous neural factors that modulate this event have
yet to be identified.
Sepsis is characterized by systemic inflammatory response
syndrome (SIRS) and multiple organ dysfunction syndrome
(MODS) [11]. Sepsis develops when the initial, appropriate host
response to an infection becomes amplified, and then dysregulat-
ed. Microorganisms and their products implicate in aberrant
inflammatory mediator production, such as cytokines and
chemokines, which in turn upregulate adhesion molecules and
stimulate leukocyte recruitment [11,12]. Activation of nuclear
factor-kB (NF-kB) results in increased gene expression and
biosynthesis of proinflammatory mediators in sepsis [13]. In
addition, extracellular signal-regulated kinase (ERK) signaling has
been shown to be important for the temporal control of NF-kB
transcriptional activity and expression of NF-kB-regulated genes,
as well as upstream activator of NF-kB [14,15]. Other studies also
highlighted the significance of NF-kB and ERK in sepsis
[14,15,16,17]. Furthermore, H2S was found to regulate inflam-
matory response in sepsis through activation of the ERK pathway
[18]. However, none has investigated the detailed signaling
mechanism of endogenous H2S in mediating neurogenic inflam-
mation in polymicrobial sepsis in a TRPV1 relevance context.
Therefore, in the present study, we hypothesized that SP is one
important neural element that implicates in H2S-induced
neurogenic inflammation in sepsis through a TRPV1 channel-
dependent mechanism, and that H2S regulates this response
through activation of the ERK-NF-kB pathway.
Materials and Methods
Animal model of polymicrobial sepsis
All experiments were approved by the Animal Ethics Commit-
tee of National University of Singapore and were conducted in
Figure 3. Effect of NaHS and capsazepine on protein levels of adhesion molecules in the lungs and liver of septic mice. Mice were
randomly given NaHS (10 mg/kg, i.p.) or vehicle (DMSO) at the same time of CLP; and capsazepine (Capz) (15 mg/kg, s.c.) or vehicle (DMSO)
30 minutes before CLP. Sham mice were used as controls. Eight hours after CLP or sham operation, protein levels of (A) P-selectin, (B) E-selectin, (C)
ICAM-1, and (D) VCAM-1 were measured. Results shown are the mean values 6 SEM (n=8–12 mice per group). *P,0.01 versus sham; **P,0.01
versus CLP+vehicle; {P,0.05 versus CLP+vehicle; {P,0.01 versus CLP+NaHS+vehicle.
doi:10.1371/journal.pone.0024535.g003
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Animal Research (permit number 732/08). Polymicrobial sepsis
was induced by CLP as previously described [10]. Male Swiss mice
(25–30 g) were anesthetized with a mixture of ketamine and
medetomindine (7.5 ml/kg, i.p.) Sham mice, which served as
controls, underwent the same procedure without CLP. All mice
received 1 ml of saline s.c. after the surgery. Capsazepine (15 mg/
kg, s.c.; Sigma-Aldrich, St. Louis, MO, USA), a TRPV1
antagonist, or vehicle (DMSO) was administrated to mice
30 minutes before surgery. The dosage of capsazepine has been
described in the literature and found to be effective in vivo
[10,19,20,21,22,23,24]. DL-propargylglycine (PAG; 50 mg/kg,
i.p.; Sigma-Aldrich), an irreversible inhibitor of CSE, was
administered either 1 hour before (‘‘prophylactic’’) or 1 hour after
(‘‘therapeutic’’) surgery. Sodium hydrosulfide (NaHS; 10 mg/kg,
i.p.; Sigma-Aldrich) was given to mice at the time of CLP. The
doses of NaHS and PAG used are well established and have been
used extensively in many animal models to study H2S [25,26,27].
Additionally, some mice received PD98059 (10 mg/kg, i.p.;
Calbiochem, San Diego, CA), a potent and selective antagonist
of MEK-1, which is the upstream kinase of ERK1/2 [28,29]. The
dose of PD98059 used is well established and has been widely used
in many animal models to block the effect of ERK1/2
[18,30,31,32,33,34]. PD98059 or vehicle (DMSO) was adminis-
trated to mice 1 hour before CLP. Mice were killed by a lethal
dose of pentobarbitone (90 mg/kg, i.p.) 8 hours after the
operation. The time point was established as described in the
literature [18] and has been used in our previous work [10].
Samples of lung, liver, and blood were collected. Plasma was
prepared from anticoagulated blood samples by centrifugation at
13,000 rpm for 10 minutes at 4uC. Samples were then stored at
280uC for subsequent analysis.
Measurement of SP levels
Samples of lung and plasma were collected from the animals.
Lung samples were homogenized in 1 ml of ice-cold SP assay
buffer for 20 seconds (Bachem, Peninsula Laboratories, San
Carlos, CA, USA). The homogenates were centrifuged (13,000 g,
20 minutes, 4uC) and the supernatants collected. The supernatants
and plasma were adsorbed on C18 cartridge columns (Bachem,
Peninsula Laboratories) as previously described [35]. The
adsorbed peptide was eluted with 1.5 ml of 75% (v/v) acetonitrile.
The samples were freeze-dried and reconstituted in the SP assay
buffer (Bachem, Peninsula Laboratories). SP content in the
samples was determined with an ELISA kit (Bachem, Peninsula
Laboratories) according to the manufacturer’s instructions. Results
were then corrected for the DNA content of the tissue samples
fluorometrically using Hoechst dye 33256 [36] and were expressed
as nanograms per microgram of DNA.
Cytokines, chemokines, and adhesion molecules
determination
Lung and liver samples were thawed, homogenized in 20 mM
phosphate buffer (pH 7.4), centrifuged (2000 g, 5 minutes, 4uC),
and the supernatants collected. Single-analyte ELISA assays were
performed for the measurement of cytokines, interleukin (IL)-1b,
IL-6, tumor necrosis factor (TNF)-a; chemokines, macrophage
inflammatory protein (MIP)-1a, MIP-2; and adhesion molecules,
P-selectin, E-selectin, intercellular adhesion molecule (ICAM)-1,
and vascular cell adhesion molecule (VCAM)-1, according to the
manufacturer’s instructions (R&D Systems, Minneapolis, MN,
USA). The lower limits of detection for the levels of IL-1b, IL-6,
TNF-a, MIP-1a, MIP-2, P-selectin, E-selectin, ICAM-1 and
VCAM-1 were 15.625, 15.625, 31.25, 3.91, 15.625, 31.25, 31.25,
62.5 and 62.5 pg/ml, respectively. The ELISA results were
reproducible with inter-assay variability of ,9.5% and intra-assay
variability of ,6.5%. Results were then corrected for the DNA
content of the tissue samples [36] and were expressed as picograms
per microgram of DNA.
Semiquantitative RT-PCR analysis
Total RNA was extracted with TRIzol reagent (Invitrogen Life
Technologies, Carlsbad, CA, USA) according to the manufacturer’s
protocol. One microgram of RNA was reverse transcribed using the
iScript cDNA synthesis kit (Bio-Rad, Hercules, CA, USA) at 25uC
for 5 minutes, 42uC for 30 minutes, followed by 85uC for
5 minutes. The cDNA was used as a template for PCR
amplification by iQ Supermix (Bio-Rad). The following primers
were used: PPT-A: 59-GCCAATGCAGAACTACGAAA-39 and
59-GCTTGGACAGCTCCTTCATC-39; r18S: 59-CCATCCAA-
TCGGTAGTAGCG-39 and 59-GTAACCCGTTGAACCCCAT-
T-39. PCR amplification was conducted in MyCycler (Bio-Rad).
The reaction mixture was first subjected to 95uC for 3 minutes,
followed by an optimal cycle of amplifications, consisting of 95uC
for 30 seconds, optimal annealing temperature for 30 seconds, and
72uC for 30 seconds. Final extension was at 72uC for 10 minutes.
PCRproducts wereanalyzed on 1.5% (w/v) agarose gels containing
0.5 mg/ml ethidium bromide.
Measurement of pulmonary edema
As an index of lung edema, the amount of extravascular lung
water was calculated according to established techniques
[37,38,39]. Briefly, mice were killed 8 hours after surgery and
blood was collected by cardiac puncture. The lungs were excised
from mice, cleared of all extrapulmonary tissue, blotted and
weighed (total lung wet weight); they were then dried in an
incubator for 48 hours at 80uC and weighed again (total dry
weight). For each animal, pulmonary edema was expressed as the
ratio of total wet weight to total dry weight.
Alanine aminotransferase (ALT) and aspartate
aminotransferase (AST) assay
Plasma ALT and AST activities were measured with the Infinity
ALT and AST liquid stable reagent (Thermo Electron Corpora-
tion, Pittsburgh, PA, USA) according to the manufacturer’s
instructions.
Nuclear extraction and measurement of NF-kB activation
Nuclear extracts from lung (50 mg) and liver (100 mg) were
prepared by using a nuclear extraction kit as described by the
manufacturer (Active Motif, Carlsbad, CA, USA). Protein concen-
trations in nuclear extracts were determined using a Bradford assay
Figure 4. Effect of NaHS and capsazepine on liver dysfunction and lung edema in septic mice. Mice were randomly given NaHS (10 mg/
kg, i.p.) or vehicle (DMSO) at the same time of CLP; and capsazepine (Capz) (15 mg/kg, s.c.) or vehicle (DMSO) 30 minutes before CLP. Sham mice
were used as controls. Eight hours after CLP or sham operation, plasma levels of (A) ALT and (B) AST, and (C) lung wet-to-dry weight ratio were
measured. Results shown are the mean values 6 SEM (n=10–15 mice per group). *P,0.01 versus sham; **P,0.01 versus CLP+vehicle; {P,0.05
versus CLP+vehicle; {P,0.01 versus CLP+NaHS+vehicle.
doi:10.1371/journal.pone.0024535.g004
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PLoS ONE | www.plosone.org 7 September 2011 | Volume 6 | Issue 9 | e24535Figure 5. Effect of PAG and capsazepine on protein and mRNA levels of SP in septic mice. Mice were randomly given PAG (50 mg/kg, i.p.)
1 hour before (‘‘prophylactic’’) or 1 hour after (‘‘therapeutic’’) CLP; and capsazepine (Capz) (15 mg/kg, s.c.) or vehicle (DMSO) 30 minutes before CLP.
Sham mice were used as controls. Eight hours after CLP or sham operation, (A) lung and (B) plasma SP levels, and (C) lung PPT-A mRNA levels were
measured. Results shown are the mean values 6 SEM (n=8–12 mice per group). *P,0.01 versus sham; **P,0.01 versus CLP+vehicle.
doi:10.1371/journal.pone.0024535.g005
Figure 6. Effect of PAG and capsazepine on protein levels of cytokines and chemokines in the lungs and liver of septic mice. Mice
were randomly given PAG (50 mg/kg, i.p.) 1 hour before (‘‘prophylactic’’; PAG+CLP+Vehicle or PAG+CLP+Capz) or 1 hour after (‘‘therapeutic’’;
CLP+PAG+Vehicle or CLP+PAG+Capz) CLP; and capsazepine (Capz) (15 mg/kg, s.c.) or vehicle (DMSO) 30 minutes before CLP. Sham mice were used
as controls. Eight hours after CLP or sham operation, protein levels of (A) TNF-a, (B) IL-1b, (C) IL-6, (D) MIP-1a and (E) MIP-2 were measured. Results
shown are the mean values 6 SEM (n=8–12 mice per group). *P,0.01 versus sham; **P,0.01 versus CLP+vehicle; {P,0.05 versus CLP+vehicle.
doi:10.1371/journal.pone.0024535.g006
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kB p65 transcription factor assay kit (Active Motif). The kit consists
of a 96-well plate, into which oligonucleotide containing the NF-kB
consensus site (59-GGGACTTTCC-39) is bound. The active form
of NF-kB in the nuclear extract specifically binds to this consensus
site and is recognized by a primary antibody specific for the
activated form of p65 of NF-kB. An horseradish peroxidase-
conjugated secondary antibody provides the basis for the colori-
metric quantification. The absorbance of the resulting solution was
measured 2 minutes later (450 nm with a reference wavelength of
655 nm), using a 96-well microplate reader (Tecan Systems,
Mannedorf, Switzerland). The wild-type consensus oligonucleotide
is provided as a competitor for NF-kB binding to monitor the
specificity of the assay. Results were expressed as fold increase over
the control group.
Western immunoblot
Lung (50 mg) and liver (100 mg) tissues were homogenized at
4uC in 1 ml of radioimmunoprecipitation assay lysis buffer
supplemented with 1% protease and 1% phosphatase inhibitor
cocktail (Sigma-Aldrich), followed by centrifugation at 14,000 g for
10 minutes at 4uC. Protein concentration in the soluble fraction
was determined by the Bradford method. Protein samples (50–
100 mg) were separated by SDS-PAGE on Novex Bis-Tris
polyacrylamide gels and transferred onto polyvinylidene difluoride
membranes by electroblotting in Novex transfer buffer (Invitrogen
Life Technologies) containing 20% (v/v) methanol. Membranes
were then washed, blocked, and probed overnight at 4uC with
rabbit anti-IkBa, phospho-IkBa, ERK1/2, and phospho-ERK1/2
(Cell Signaling Technology, Beverly, MA, USA; 1:1000 dilution
for all), followed by secondary detection for 2 hours with an
horseradish peroxidase-conjugated, goat anti-rabbit IgG (Santa
Cruz Biotechnology, CA, USA; 1:1000 dilution). Membranes were
washed and then incubated in SuperSignal West Pico chemilumi-
nescent substrate (Pierce Biotechnology, Rockford, IL, USA)
before exposure to X-ray films (LC-XPosure, Pierce Biotechnol-
ogy). Gels were calibrated by protein kaleidoscope standards (Bio-
Rad). Hypoxanthine-guanine phosphoribosyltransferase (HPRT)
(Santa Cruz Biotechnology; 1:2000 dilution) was applied as an
internal control to normalize protein loading. The intensity of
bands was quantified using LabWorks Image Analysis software
(Ultra-Violet Products Ltd., Cambridge, UK).
Figure 7. Effect of PAG and capsazepine on protein levels of adhesion molecules in the lungs and liver of septic mice. Mice were
randomly given PAG (50 mg/kg, i.p.) 1 hour before (‘‘prophylactic’’; PAG+CLP+Vehicle or PAG+CLP+Capz) or 1 hour after (‘‘therapeutic’’;
CLP+PAG+Vehicle or CLP+PAG+Capz) CLP; and capsazepine (Capz) (15 mg/kg, s.c.) or vehicle (DMSO) 30 minutes before CLP. Sham mice were used
as controls. Eight hours after CLP or sham operation, protein levels of (A) P-selectin, (B) E-selectin, (C) ICAM-1, and (D) VCAM-1 were measured. Results
shown are the mean values 6 SEM (n=8–12 mice per group). *P,0.01 versus sham; **P,0.01 versus CLP+vehicle.
doi:10.1371/journal.pone.0024535.g007
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The data were expressed as mean 6 SEM. The significance of
difference among groups was evaluated by one-way ANOVA with
a post-hoc Tukey’s test for multiple comparisons. A value of
P,0.05 was regarded as statistically significant.
Results
Capsazepine attenuates endogenous SP concentrations
in both septic and septic mice administrated with NaHS
The concentration of SP in both lung (Fig. 1A) and plasma
(Fig. 1B) was significantly increased after induction of sepsis.
Densitometric analysis of PCR products on agarose gel showed
that pulmonary PPT-A mRNA expression correlated well with
protein levels (Fig. 1C). Administration of capsazepine significantly
suppressed lung (Fig. 1A) and plasma (Fig. 1B) SP levels.
Consistently, transcriptional level of PPT-A gene expression was
markedly reduced upon treatment with capsazepine (Fig. 1C).
Administration of NaHS resulted in a further rise in the
pulmonary (Fig. 1A) and plasma (Fig. 1B) SP levels in sepsis.
Likewise, pulmonary mRNA level of PPT-A was significantly
elevated in septic mice administrated with NaHS (Fig. 1C).
Importantly, in the presence of NaHS, a significant attenuation of
endogenous SP concentrations occurred in both lung (Fig. 1A) and
plasma (Fig. 1B), consistent with a parallel decrease in pulmonary
gene expression for SP (Fig. 1C) in septic mice treated with
capsazepine.
The attenuated SP levels correlates with reduced
production of proinflammatory molecules in both septic
and septic mice administrated with NaHS
The protein levels of proinflammatory cytokines, TNF-a, IL-1b,
IL-6; chemokines, MIP-1a, MIP-2 (Fig. 2A–E); and adhesion
molecules, P-selectin, E-selectin, ICAM-1, and VCAM-1 (Fig. 3A–
D) in both lung and liver homogenates showed a marked rise in
septic mice as compared with sham mice. All of these were
significantly lowered by capsazepine (Fig. 2 and 3). Administration
of NaHS in septic mice further enhanced the production of these
mediators (Fig. 2 and 3) but capsazepine alleviated them (Fig. 2
and 3). At the transcriptional level, similar trends were observed
that correlated well with the protein levels in both septic and septic
mice administrated with NaHS (data not shown).
Capsazepine protects against MODS in both septic and
septic mice administrated with NaHS
MODS is recognized to be the ultimate cause of death in
patients with sepsis [11]. In an attempt to determine if TRPV1
antagonism by capsazepine is beneficial in preventing MODS, we
determined pulmonary edema levels to assess the severity of lung
injury [35], and measured plasma ALT and AST activities as
indices of hepatic dysfunction [40]. Evidence of lung and liver
damage after septic injury was confirmed by the heightened levels
of pulmonary edema as indicated by wet-to-dry weight ratio
(Fig. 4C), and increased activities of plasma ALT (Fig. 4A) and
AST (Fig. 4B), respectively. However, septic mice treated with
capsazepine showed significantly lower lung wet-to-dry weight
ratio (Fig. 4C), and plasma ALT (Fig. 4A) and AST (Fig. 4B)
activities. Administration of NaHS in septic mice further
exacerbated these organ injury parameters (Fig. 4A–C) but
capsazepine alleviated these deleterious effects (Fig. 4A–C).
Capsazepine has no effect on PAG-mediated attenuation
of SP levels in sepsis
Our data showed that prophylactic or therapeutic administra-
tion of PAG mitigated both pulmonary (Fig. 5A) and plasma
(Fig. 5B) SP levels in sepsis. This is consistent with a parallel
decrease in pulmonary gene expression for SP (Fig. 5C) in septic
mice received PAG intervention. However, there were no
significant differences in both the protein and transcriptional
levels of SP in septic mice treated with both PAG and capsazepine
when compared to their vehicle control counterparts (Fig. 5A–C).
Inhibition of H2S formation impaired proinflammatory
molecules production after septic injury, but capsazepine
has no effect on them
We found that both pre- and post-treatment of PAG decreased
protein levels of proinflammatory cytokines, TNF-a, IL-1b, IL-6;
chemokines, MIP-1a, MIP-2 (Fig. 6A–E); and adhesion molecules,
P-selectin, E-selectin, ICAM-1, and VCAM-1 (Fig. 7A–D) in both
lung and liver homogenates, as compared with vehicle-injected
septic mice that exhibited significant increments in the protein
levels of these inflammatory mediators. A similar profile of the
mRNA expression for these molecules was also observed (data not
shown). However, there were no significant differences in the levels
of these inflammatory mediators, at both the protein (Fig. 6 and 7)
and transcriptional (data not shown) levels, in septic mice treated
with both PAG and capsazepine when compared to those that
received PAG only.
Beneficial effects of capsazepine and PAG are not
additive in protection against MODS in sepsis
Further evidence of neurogenic contribution of H2Si n
mediating sepsis-associated MODS was demonstrated by non-
significant changes of pulmonary edema levels, plasma ALT and
AST activities in septic mice treated with both PAG and
capsazepine, as compared with their vehicle control counterparts
(Fig. 8A–C). These data demonstrated that absence of H2S alone is
sufficient to ameliorate lung and liver dysfunction as indicated by
decreased levels of lung wet-to-dry weight ratio (Fig. 8C), and
reduced activities of plasma ALT (Fig. 8A) and AST (Fig. 8B),
respectively.
Effect of capsazepine on ERK1/2 activation in H2S-induced
neurogenic inflammation in sepsis
To investigate the signaling mechanisms by which H2S
regulates TRPV1-mediated neurogenic inflammation in sepsis,
we evaluated the ERK1/2 and NF-kB signaling pathways, with the
usage of capsazepine, using two different and complementary
approaches: exogenous administration of NaHS as an H2S donor
and inhibition of endogenous H2S formation by PAG. We
observed activation of pulmonary and hepatic ERK1/2 in septic
mice as compared with sham mice (Fig. 9A). Upon treatment of
Figure 8. Effect of PAG and capsazepine on liver dysfunction and lung edema in septic mice. Mice were randomly given PAG (50 mg/kg,
i.p.) 1 hour before (‘‘prophylactic’’) or 1 hour after (‘‘therapeutic’’) CLP; and capsazepine (Capz) (15 mg/kg, s.c.) or vehicle (DMSO) 30 minutes before
CLP. Sham mice were used as controls. Eight hours after CLP or sham operation, plasma levels of (A) ALT and (B) AST, and (C) lung wet-to-dry weight
ratio were measured. Results shown are the mean values 6 SEM (n=10–15 mice per group). *P,0.01 versus sham; **P,0.01 versus CLP+vehicle;
{P,0.05 versus CLP+vehicle.
doi:10.1371/journal.pone.0024535.g008
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abolished (Fig. 9A). Administration of exogenous NaHS further
enhanced tissue ERK1/2 activation in sepsis, whereby capsazepine
treated, NaHS-injected septic mice revealed significantly reduced
lung and liver phospho-ERK1/2 expressions (Fig. 9A). Addition-
ally, prophylactic or therapeutic administration of PAG markedly
suppressed tissue phosphorylation of ERK1/2 in sepsis (Fig. 9B).
Interestingly, the status of ERK1/2 activation in septic mice
administrated with both PAG and capsazepine remained un-
changed when compared to those that received PAG only (Fig. 9B).
Effect of capsazepine on IkBa phosphorylation and
degradation levels and NF-kB activity in H2S-induced
neurogenic inflammation in sepsis
Subsequently, we analyzed whether ERK1/2 signaling leads to
activation of inhibitory kBa (IkBa) and NF-kBi nH 2S-induced
neurogenic inflammation in sepsis. Capsazepine greatly reduced
pulmonary and hepatic levels of phospho-IkBa in septic mice as
compared to the elevated levels detected in untreated septic mice
(Fig. 10A). Consistently, phospho-IkBa levels in the lungs and liver
of septic mice injected with NaHS were greatly enhanced; while
these levels were significantly suppressed by capsazepine (Fig. 10A).
In contrast, PAG intervention drastically reduced lung and liver
phospho-IkBa levels in sepsis and capsazepine has no effect on
them (Fig. 10B).
More importantly, assessment of IkBa degradation displayed a
similar profile that correlated well with the levels of phospho-IkBa,
with untreated septic mice showing a significant reduction in lung
and liver IkBa levels in comparison with the heightened levels
exhibited in capsazepine treated septic mice (Fig. 10C). Likewise,
the expression levels of IkBa in lung and liver tissues from septic
mice injected with NaHS were again lowered; while these levels
were elevated with capsazepine (Fig. 10C). Additionally, treatment
with PAG markedly enhanced tissue IkBa expression levels in
comparison to their vehicle control counterparts, suggesting an
obvious inhibition of IkBa degradation (Fig. 10D). However,
treatment of capsazepine failed to further modulate these levels
(Fig. 10D).
Next, we examined whether phosphorylation and degradation
of IkBa result in NF-kB nuclear translocation. Our results showed
that capsazepine significantly decreased the DNA-binding activity
of nuclear NF-kB in the lungs and liver of septic mice (Fig. 11A).
Exogenous administration of NaHS further amplified the
activation of NF-kB while treatment with capsazepine significantly
disrupted the activity of NF-kB (Fig. 11A). In the absence of
endogenous H2S, the DNA-binding activity of nuclear NF-kB was
greatly reduced (Fig. 11B). As anticipated, we noticed no
difference in lung and liver NF-kB activation from septic mice
treated with both PAG and capsazepine as compared with their
vehicle control counterparts (Fig. 11B).
Finally, to examine if ERK1/2 activation occurs upstream of
NF-kB, we measured tissue NF-kB activity in the presence of
PD98059, a potent and selective antagonist of MEK-1 that is the
upstream kinase of ERK1/2 [28,29]. Our results showed that
PD98059 significantly decreased the DNA-binding activity of
nuclear NF-kB in the lungs and liver of septic mice (Fig. 11C). In
the presence of NaHS, a marked attenuation of tissue NF-kB
activation by PD98059 was observed in sepsis, thus providing
convincing evidence that ERK1/2 activation occurs upstream of
NF-kB (Fig. 11C).
Discussion
Sepsis remains an important global healthcare problem even in
the modern era of critical care management. Thus, identifying
endogenous neural elements that modulate H2S-induced neuro-
genic inflammation in sepsis and elucidating the underlying
molecular mechanisms by which this occurs are of paramount
importance. Our previous study demonstrated that H2S promotes
TRPV1-mediated neurogenic inflammation in polymicrobial
sepsis [10]. In the present study, we showed that overproduction
of SP significantly increases the severity of sepsis in a TRPV1-
dependent manner; and that this phenomenon occurred under the
influences of the proinflammatory effects of H2S. Additionally, we
found that the underlying signal transduction pathway by which
H2S, SP and TRPV1 interact to instigate neural inflammatory
processes involve activation of the ERK-NF-kB pathway.
In recent years, the role of SP in the regulation of inflammatory
conditions in lipopolysaccharide-evoked endotoxemia, CLP-in-
duced sepsis, as well as human sepsis and septic shock has been
suggested [41,42,43]. Of even greater significance, H2S has been
shown to implicate in neurogenic inflammation mediated by SP
and TRPV1. By stimulating TRPV1-expressing sensory neurons,
H2S provoked the release of SP from isolated guinea pig airways
[5]. Likewise, heightened circulatory level of SP was observed in
normal mice administrated with NaHS [19]. Notably, in both
studies, SP levels were greatly attenuated by capsaicin desensiti-
zation or by capsazepine administration. Besides, H2S induced
contraction in rat urinary bladder via a neurogenic mechanism
that involved TRPV1 stimulation with consequent release of
tachykinin [44,45]. Furthermore, endogenous H2S was found to
modulate sepsis-associated lung injury and caerulein-induced
acute pancreatitis through upregulation of SP in the lungs and
pancreas, respectively [43,46]. Here, we show that H2S regulates
TRPV1-mediated neurogenic inflammation in sepsis through
upregulation of pulmonary and plasma SP. Our findings are
consistent with earlier observations and reinforce the essential role
of SP, and its interaction with H2S. It must be noted, however,
that with the usage of capsazepine, a synthetic competitive
antagonist of TRPV1; our results provide the first pharmacological
evidence that H2S provokes tachykinin-mediated neurogenic
inflammatory responses involving SP in sepsis in a TRPV1-
dependent manner.
In the first report showing the relations between H2S and
infection, endogenous vascular H2S content was increased in rats
with septic and endotoxic shock. It was suggested that excess H2S
production was involved in pathophysiological processes during
shock [9]. Consistently, our previous study has shown that CLP-
induced sepsis significantly increased the plasma H2S level and the
liver CSE activity in septic mice. Prophylactic and therapeutic
administration of PAG in septic mice completely abolished the
Figure 9. Effect of NaHS or PAG and capsazepine on ERK1/2 activation in the lungs and liver of septic mice. Mice were randomly given
NaHS (10 mg/kg, i.p.) at the same time of CLP or PAG (50 mg/kg, i.p.) 1 hour before (‘‘prophylactic’’) or 1 hour after (‘‘therapeutic’’) CLP; and
capsazepine (Capz) (15 mg/kg, s.c.) or vehicle (DMSO) 30 minutes before CLP. Sham mice were used as controls. Eight hours after CLP or sham
operation, effect of (A) NaHS or (B) PAG and capsazepine on phospho-ERK1/2 and total ERK1/2 expression levels were measured. A representative
western blot image is shown, with densitometry data expressed as average ratios of phospho-ERK1/2 to total ERK1/2. Results shown are the mean
values 6 SEM (n=6 mice per group). *P,0.01 versus sham; **P,0.01 versus CLP+vehicle; {P,0.01 versus CLP+NaHS+vehicle.
doi:10.1371/journal.pone.0024535.g009
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PLoS ONE | www.plosone.org 13 September 2011 | Volume 6 | Issue 9 | e24535Figure 10. Effect of NaHS or PAG and capsazepine on IkBa phosphorylation and degradation levels in the lungs and liver of septic
mice. Mice were randomly given NaHS (10 mg/kg, i.p.) at the same time of CLP or PAG (50 mg/kg, i.p.) 1 hour before (‘‘prophylactic’’) or 1 hour after
(‘‘therapeutic’’) CLP; and capsazepine (Capz) (15 mg/kg, s.c.) or vehicle (DMSO) 30 minutes before CLP. Sham mice were used as controls. Eight hours
after CLP or sham operation, effect of NaHS or PAG and capsazepine on (A and B) phospho-IkBa and (C and D) IkBa expression levels were measured.
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significant reduction in plasma H2S level [10]. Furthermore,
capsazepine has no effect on endogenous generation of H2Si n
sepsis. Employing the same experimental approach, it was
demonstrated that hepatic CSE activity and plasma H2S level in
septic mice treated with capsazepine and those treated with both
PAG and capsazepine were comparable to their vehicle control
counterparts [10]. Here, we report that capsazepine significantly
attenuated endogenous SP levels in both septic and septic mice
administrated with NaHS. Moreover, capsazepine has no effect on
PAG-mediated attenuation of SP level in sepsis. Taken together,
these findings suggest that endogenous H2S signaled via TRPV1
which resulted in the subsequent release of SP, thereby allowing
SP to elicit its potent proinflammatory effects in sepsis. It is worth
mentioning that TRPV1 is broadly expressed in all ‘‘port of entry’’
tissues such as the skin, gut, airway and conjunctiva [2,47], hence
we restricted measurement of SP to the lungs. Nevertheless, a
systemic role of SP via the circulatory system was investigated in
this study to substantiate its generalized role in mediating
neurogenic inflammation in sepsis.
SIRS and MODS are major hallmarks of sepsis. Excessive
synthesis of inflammatory molecules in organs remote from the
initial insult synergistically interact to mediate tissue damage,
followed by cardiovascular collapse, MODS, and death of the host
[11]. The current study revealed that pharmacological blockade of
TRPV1 markedly reduced pulmonary and hepatic levels of IL-1b,
IL-6, TNF-a, MIP-1a, MIP-2, P-selectin, E-selectin, VCAM-1
and ICAM-1 in both septic and septic mice administrated with
NaHS. Likewise, a significant protection against lung injury and
liver dysfunction, as indicated by pulmonary edema and serum
ALT and AST activities respectively, was conferred by capsaze-
pine. Importantly, both observations corresponded with concur-
rent attenuation of SP level, suggesting that H2S stimulation of
TRPV1 and the subsequent release of SP can induce upregulation
of proinflammatory mediators that implicated in SIRS and work
in conjunction with them to initiate MODS. The observed
protection against MODS was further associated with improved
survival benefits, as capsazepine has been previously reported to
reduce mortality in sepsis even in the presence of NaHS [10]. To
this regard, it should be noted that lung and liver were chosen for
investigation primarily because lungs are often the first organ to
succumb post systemic insults, and liver represents an important
organ not only in host defense [48], but in addition that CSE is
highly expressed in hepatocytes [49]. Collectively, our results
established H2S stimulation of TRPV1 and the downstream
release of SP as a key element in the transition of infection and
SIRS to MODS in sepsis, and identified TRPV1 antagonist as a
possible therapeutic target for the treatment of polymicrobial
sepsis.
In contrast, beneficial effects of TRPV1 antagonism in
ameliorating SIRS and MODS in sepsis were diminished when
endogenous synthesis of H2S was blocked as seen in septic mice
received PAG intervention as compared to the same mice treated
with capsazepine. It appears that inhibition of H2S generation
alone is sufficient to account for these observations, and that the
presence or absence of TRPV1 antagonism makes no difference.
Nonetheless, with regard to the inhibitory effects of CSE
synthesizing activity, it should be underlined that the effects of
PAG alone seem not to be a consequence of blood pressure
changes, given that at the doses used PAG did not significantly
change blood pressure [50]. Besides, the effect of capsazepine is
not entirely secondary to an enhanced formation of H2S. Since
sepsis is a multifactorial disease, other inflammatory mediators
may stimulate TRPV1 and trigger the release of SP. Nevertheless,
we ascertained from our data that sepsis has a significant sensory
neurogenic component that involved SP and mediated by H2Si na
TRPV1-dependent manner.
Although convincing data have suggested the relevance of
ERK1/2 signaling to H2S, their association with TRPV1 remains
unknown [18,51,52,53]. In the current study, we showed that
pharmacological antagonism of TRPV1 inhibits phosphorylation
of ERK1/2 and IkBa, concurrent with inhibition of IkBa
degradation and DNA binding activity of nuclear NF-kB, in both
septic and septic mice administrated with NaHS. Conversely, in
the absence of H2S, capsazepine has no effect on PAG-mediated
suppression of these parameters in sepsis. These findings not only
indicate that H2S, SP and TRPV1 interact to instigate neurogenic
inflammation in sepsis through activation of the ERK-NF-kB
pathway, but also added to the growing evidence about the
involvement of ERK1/2 in regulating the activity of NF-kB
[14,15], and the potential association between H2S and ERK-NF-
kB [18,51,52,53]. Furthermore, the observed suppression of tissue
NF-kB activation in the presence of PD98059, a selective inhibitor
of MEK-1 that is the upstream kinase of ERK1/2, directly
ascertained that ERK1/2 signaling occurs upstream of NF-kB
activation. Reinforcing our findings that H2S induces TRPV1-
mediated neurogenic inflammation through activation of the
ERK-NF-kB pathway, H2S has been reported previously, using
specific inhibitors for ERK and NF-kB, to alleviate tissue
inflammatory cytokines and chemokines production in septic mice
and normal mice injected with NaHS, respectively [18,54].
Nevertheless, H2S has been linked to a number of other pathways
[55,56,57,58], hence, alternative mechanisms may exist which act
in synergism with ERK signaling cascade to modulate the activity
of NF-kB in sepsis. Additionally, since polyclonal antibody against
p65 subunit was employed to investigate the activity of NF-kB, our
results demonstrate that NF-kB dimers containing p65 may play a
crucial role in H2S-provoked inflammation and injury response
seen in this study.
Our findings suggest a proinflammatory role of H2S in sepsis,
however, a recent paper by Spiller et al. [59] reports the anti-
inflammatory properties of H2S. The inconsistency may be a result
of the dose of NaHS used. We used NaHS at a dose of 10 mg/kg,
which increased plasma concentration of H2S significantly and
caused obvious lung and liver inflammation [10,19,26] whereas
study by Spiller et al. used three doses of NaHS (10, 30, or
100 mmol/kg) that approximated the physiological concentrations
of H2S. Importantly, it has been suggested that low (physiological)
concentrations of H2S tend to be cytoprotective and anti-
inflammatory while higher concentrations are likely to be cytotoxic
and proinflammatory [6]. In addition, experimental differences
that include health status, age, and gender of the animals;
commercial sources of NaHS and PAG; and level of severity of
sepsis may explain the opposing findings between us and them.
Although the present study offers the possibility that H2S may
activate TRPV1, the precise molecular site of action and the
molecular mechanisms underlying it remain unknown. It could be
possible that the neuropeptide release observed with H2Si svia an
A representative western blot image is shown, with densitometry data expressed as average ratios of phospho-IkBa to HPRT and IkBa to HPRT levels.
Results shown are the mean values 6 SEM (n=6 mice per group). *P,0.01 versus sham; **P,0.01 versus CLP+vehicle; {P,0.05 versus CLP+vehicle;
{P,0.01 versus CLP+NaHS+vehicle.
doi:10.1371/journal.pone.0024535.g010
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tors evoked by H2S. Furthermore, the specific cell types that
respond to H2S stimulation of TRPV1 activation, as well as the
types of cells that bind to SP and mediate ERK-NF-kB signaling,
remain to be identified. Molecular mechanisms that lead to
reduced ERK1/2 phosphorylation and NF-kB activation with
PAG are issues deserving further studies. Finally, investigation on
the role of H2S in pathological conditions has been hampered by
the paucity of specific pharmacological tools. Most irreversible
inhibitors of CSE, including PAG, are of low potency, of low
selectivity and of limited cell-membrane permeability that also
non-specifically interfere with other pyridoxal-59-phosphate-de-
pendent enzymes [6,8]. It is clear that newer and more promising
chemical tools are required to probe deeper the complex biological
roles of H2S.
In conclusion, we propose that H2S regulates TRPV1-mediated
neurogenic inflammation in polymicrobial sepsis through en-
hancement of SP production and activation of the ERK-NF-kB
pathway. Importantly, the H2S-TRPV1-SP-ERK1/2-IkBa-NF-kB
signal transduction pathway contributes to SIRS and MODS in
sepsis (Fig. 12). Collectively, our results contribute to a better
understanding of the precise mechanism underlying the proin-
flammatory effects of H2S in the pathophysiology of sepsis in a
TRPV1 relevance context and provide further insight into the
development of new therapeutic intervention for sepsis and other
inflammatory pathologies.
Figure 11. Effect of NaHS or PAG and capsazepine and effect of NaHS and PD98059 on NF-kB activation in nuclear extracts of lung
and liver tissues in septic mice. Mice were randomly given NaHS (10 mg/kg, i.p.) at the same time of CLP or PAG (50 mg/kg, i.p.) 1 hour before
(‘‘prophylactic’’) or 1 hour after (‘‘therapeutic’’) CLP; and capsazepine (Capz) (15 mg/kg, s.c.) or vehicle (DMSO) 30 minutes before CLP. Some mice
were injected PD98059 (10 mg/kg, i.p.) or vehicle (DMSO) 1 hour before CLP. Sham mice were used as controls. Eight hours after CLP or sham
operation, effect of (A) NaHS or (B) PAG and capsazepine and (C) effect of NaHS and PD98059 on the DNA-binding activity of NF-kB were measured.
Results shown are the mean values 6 SEM (n=8–12 mice per group). *P,0.01 versus sham; **P,0.01 versus CLP+vehicle; {P,0.01 versus
CLP+NaHS+vehicle. {P,0.01 versus CLP+NaHS+vehicle.
doi:10.1371/journal.pone.0024535.g011
Figure 12. Schematic summary of signaling events in H2S-induced neurogenic inflammation in a murine model of polymicrobial
sepsis. H2S has been demonstrated to be overproduced in sepsis. H2S stimulation of TRPV1 and the downstream release of SP lead to the activation
of ERK1/2, which subsequently induces the phosphorylation and degradation of IkBa, as well as the translocation and activation of NF-kB, thereby
leading to SIRS and MODS characteristic of severe sepsis. r indicates exogenous administration; indicates inhibition.
doi:10.1371/journal.pone.0024535.g012
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